Structure Info
- Chemspace ID
- CSSS06744597765 (In-Stock Screening Compounds)
- IUPAC Name
- 1-({4-[(2S)-5-(carbamoylamino)-2-[(2S)-2-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido]-3-methylbutanamido]pentanamido]phenyl}methyl)-4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-1-ium chloride
- Mol formula
- C50H63Cl2FN10O9
- Mol weight
- 1038 Da
- Catalog Number(s)
- HY-148871, MS-31887
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -0.65
- Heavy atoms count
- 72
- Rotatable bond count
- 26
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.44
- Polar surface area (Å)
- 240
- Hydrogen bond acceptors count
- 12
- Hydrogen bond donors count
- 6
- Zoom the structure
- CSSS06744597765
Items Overall 6 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, € | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress EU | 10 days | Sweden To: | 99 | 1 mg | 480 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 1,343 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 2,149 | |
Description: Names: Mc-Val-Cit-PAB-Gefitinib (chloride); Product Description: Mc-Val-Cit-PAB-Gefitinib chloride is a agent-linker conjugates for ADC. Mc-Val-Cit-PAB-Gefitinib chloride consists of Gefitinib (HY-50895) (an EGFR tyrosine kinase inhibitor) and the ADC linker Mc-Val-Cit-PAB; Target: Drug-Linker Conjugates for ADC | ||||||
| MedChemExpress | 10 days | United States To: | 99 | 1 mg | 559 | |
| MedChemExpress | 10 days | United States To: | 99 | 5 mg | 1,569 | |
| MedChemExpress | 10 days | United States To: | 99 | 10 mg | 2,549 | |
Description: Names: Mc-Val-Cit-PAB-Gefitinib (chloride); Product Description: Mc-Val-Cit-PAB-Gefitinib chloride is a agent-linker conjugates for ADC . Mc-Val-Cit-PAB-Gefitinib chloride consists of Gefitinib (HY-50895) (an EGFR tyrosine kinase inhibitor) and the ADC linker Mc-Val-Cit-PAB .; Target: Drug-Linker Conjugates for ADC | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire